GlucaGen Hypokit 1 mg

• Keep this leaflet. You may need to read it again.
• If you have any further questions, ask your doctor, pharmacist or nurse.
• This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
• If you get any side effects, talk to your doctor. This includes any possible side effects not listed in this leaflet. See section 4.

1. What GlucaGen HypoKit is and what it is used for
2. What you need to know before you use GlucaGen HypoKit
3. How to use GlucaGen HypoKit
4. Possible side effects
5. How to store GlucaGen HypoKit
6. Contents of the pack and other information
7. Additional information for medical professionals

• Make sure that your family members, people you work with or close friends know about GlucaGen HypoKit. Tell them that if you pass out (become unconscious) they should use GlucaGen HypoKit straight away.
• Show your family members and others where you keep this kit and how to use it. They must act quickly – if you are unconscious for a period of time it may be harmful. It is important they are trained and know how to use GlucaGen HypoKit before you need it.
• The syringe does not contain GlucaGen. The water in the syringe must be mixed with the compacted GlucaGen powder in the vial before the injection. Tell your family members and others to follow the instructions in section 3: How to use GlucaGen HypoKit.
• Any mixed GlucaGen that is not used must be thrown away.
• After using GlucaGen HypoKit, you or someone else must contact your doctor or a healthcare provider. You need to find out why you had very low blood sugar and how to avoid it happening again.

• you are allergic to glucagon or any of the other ingredients of this medicine (listed in section 6).
• you have a tumour in your adrenal gland.

If any of these apply, do not use GlucaGen HypoKit.

Talk to your doctor, pharmacist or nurse before you use GlucaGen HypoKit.

GlucaGen will not work properly if:

• you have been fasting for a long time
• you have low levels of adrenaline
• you have low blood sugar caused by drinking too much alcohol
• you have a tumour that releases glucagon or insulin

If any of these apply, talk to your doctor or pharmacist.

The following medicines can affect the way GlucaGen HypoKit works:

• insulin – used to treat diabetes
• indomethacin – used to treat joint pain and stiffness

The following medicines may be affected by GlucaGen HypoKit:

• warfarin – used to prevent blood clots. GlucaGen may increase the blood-thinning effect of warfarin.
• beta-blockers – used to treat high blood pressure and irregular heart beat. GlucaGen HypoKit may increase blood pressure and pulse, this will only last a short time.

If any of the above apply to you (or you are not sure), talk to your doctor or pharmacist before having GlucaGen Hypokit.

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.

If you experience very low blood sugar, when you are pregnant or breast-feeding, think you might be pregnant or are planning to have a baby, you can use GlucaGen HypoKit.

Ask your doctor or pharmacist for advice before taking any medicine, if you are pregnant.

Wait until the effects of very low blood sugar have worn off, before driving or using any tools or machines.

GlucaGen contains less than 1mmol sodium (23mg) per maximum dose (2 ml), that is to say essentially ‘sodium-free’.

1. Remove the plastic cap from the vial. Pull the needle cover off the syringe. Do not remove the plastic back-stop from the syringe. Insert the needle through the rubber stopper (within the marked circle) of the vial containing GlucaGen and inject all the liquid from the syringe into the vial.

2. Without taking the needle out of the vial, gently shake the vial until GlucaGen has completely dissolved, and the solution is clear.

3. Make sure the plunger is completely down. While keeping the needle in the liquid, slowly withdraw all the solution back into the syringe. Do not pull the plunger out of the syringe. It is important to remove any air bubbles from the syringe:

• With the needle pointing upwards, tap the syringe with your finger
• Push the plunger slightly to release any air that has collected at the top of the syringe.

Continue to push the plunger until you have the correct dose for injection. A small amount of liquid will be pushed out when you do this.

See How much to use, below.

4. Inject the dose under the skin or into a muscle.

5. Turn the unconscious person on their side to prevent choking.

6. Give the person a high sugar snack like sweets, biscuits or fruit juice as soon as he or she regains consciousness and is able to swallow. The high sugar snack will stop the low blood sugar happening again.

After using GlucaGen HypoKit, you or someone else must contact your doctor or a healthcare provider. You need to find out why you had very low blood sugar and how to avoid it happening again.

The recommended dose is:

• Adults: inject all of the medicine (1 ml) – this is marked as “1” on the syringe.
• Children younger than 8 years or children older than 8 years who weigh less than 25 kg: inject half of the medicine (0.5 ml) – this is marked as “0.5” on the syringe.
• Children older than 8 years or children younger than 8 years who weigh more than 25 kg: inject all of the medicine (1 ml) – this is marked as “1” on the syringe.

Too much GlucaGen may lead to nausea and cause you to be sick (vomit). Specific treatment is not usually necessary.

Very rare: may affect up to 1 in 10,000 people

• allergic reaction – the signs may include wheezing, sweating, rapid heart beat, rash, swollen face and collapse.

• Talk to a doctor immediately, if you notice any of the above serious side effects.

Common: may affect up to 1 in 10 people

• feeling sick (nausea).

Uncommon: may affect up to 1 in 100 people

• being sick (vomiting).

Rare: may affect up to 1 in 1,000 people

• stomach (abdominal) pain.

Not known: frequency cannot be estimated from the available data

• injection site reactions.

• If you get any side effects above, talk to your doctor. This includes any possible side effects not listed in this leaflet.

If you get any side effects, talk to your doctor. This includes any possible side effects not listed in this leaflet. You can also report side effects directly (see details below). By reporting side effects, you can help provide more information on the safety of this medicine.

United Kingdom

or search for MHRA Yellow Card in the Google Play or Apple App Store

• The active substance is glucagon 1 mg as hydrochloride, produced in yeast by recombinant DNA.
• The other ingredients are lactose monohydrate, water for injections, hydrochloric acid and/or sodium hydroxide (for pH adjustment).

GlucaGen is supplied as a sterile white powder of glucagon in a vial, with a solvent in a disposable syringe. The powder is compacted. Once mixed, the solution contains glucagon 1 mg/ml.

Administer by subcutaneous or intramuscular injection. If the patient does not respond within 10 minutes, intravenous glucose should be given. When the patient has responded to the treatment, give oral carbohydrate to restore the liver glycogen and prevent relapse of hypoglycaemia.

Oral carbohydrates should be given when the procedure has ended, if this is compatible with the diagnostic procedure concerned. Remember that GlucaGen has the opposite effect of insulin. With endoscopy or radiography procedures, take extra care in administering GlucaGen to patients with diabetes or to people with a heart condition.

Note that a syringe with a thinner needle and a finer graduation may be more suitable for use in diagnostic procedures.

Examination of the gastrointestinal tract:

Doses vary from 0.2 – 2 mg depending on the diagnostic technique used and the route of administration. The diagnostic dose for relaxation of the stomach, duodenal bulb, duodenum and small bowel is 0.2 – 0.5 mg given intravenously or 1 mg given intramuscularly. The dose to relax the colon is 0.5 – 0.75 mg intravenously or 1 – 2 mg intramuscularly. The onset of effect after an intravenous injection of 0.2 – 0.5 mg occurs within one minute and the duration of the effect is between 5 – 20 minutes. The onset of action after an intramuscular injection of 1 – 2 mg occurs after 5 – 15 minutes and lasts approximately 10 – 40 minutes.

Blood pressure changes, rapid heartbeat, hypoglycaemia and hypoglycaemic coma.